ɬŔď·¬

Annual Meeting

Biochemists face the climate challenge

Learn about the Discover BMB 2024 symposium by the Maximizing Access Committee
Karla Neugebauer Kayunta Johnson–Winters
By Karla Neugebauer and Kayunta Johnson–Winters
Sept. 14, 2023

Everyone knows coral bleaching occurs when seawater gets hot. Biochemists ask: How?

Corals die when their photosynthetic algal symbionts experience heat stress and exude hydrogen peroxide, causing coral tissue to expel the algae. Thus, coral bleaching is a biochemical process that we can understand and engage with, imagining new solutions to climate changes that degrade our planet.

Submit an abstract

Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30.

The Centers for Disease Control and Prevention have long embraced “One Health,” the concept that a healthy planet is required for human health. Recently, the National Institutes of Health launched their Climate Change and Health Initiative. Biochemistry is central to preserving the natural world and developing fully renewable building materials, novel foods and health care solutions.

This session will explore how the living world experiences changes in temperature, pH, salt, nutrients, desiccation and other conditions. The speakers will illuminate the cell and molecular mechanisms underlying coral symbiosis, thermal adaptations of marine organisms, temperature-dependent mutagenesis and transposition in the fungal pathogen Cryptococcus neoformans, and the endocrine underpinnings of environmental influences on human health. This session is for the next generation of biochemists who will meet the climate challenge.

Keywords: One Health, thermal adaptation, symbiosis.

Who should attend: The next generation of biochemists who will save the planet.

Theme song: by John Lennon

This session is powered by the courage to face humanity’s greatest challenge.

Biochemistry and climate change

Asiya Gusa, Duke University 

James A. DeMayo, University of Colorado–Denver

Yixian ZhengCarnegie Institution for Science

Teresa HortonNorthwestern University

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Karla Neugebauer
Karla Neugebauer

Karla Neugebauer is a professor of molecular biophysics and biochemistry at Yale University.

Kayunta Johnson–Winters
Kayunta Johnson–Winters

Kayunta Johnson–Winters is an associate professor of chemistry and biochemistry at the University of Texas, Arlington.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Omega-3 fats linked to healthy aging and improved heart metabolism
Journal News

Omega-3 fats linked to healthy aging and improved heart metabolism

Aug. 1, 2025

Scientists from the University of Iowa find that a diet high in polyunsaturated fatty acids from fish oil increases cardiac triglyceride uptake and improves insulin sensitivity. Read more about this recent JLR study.

RA patient blood reveals joint innerworkings
Journal News

RA patient blood reveals joint innerworkings

July 25, 2025

Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
Feature

Using 'nature’s mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.